HIGH-GRADE SEROUS OVARIAN CARCINOMA
Clinical trials for HIGH-GRADE SEROUS OVARIAN CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HIGH-GRADE SEROUS OVARIAN CARCINOMA trials appear
Sign up with your email to follow new studies for HIGH-GRADE SEROUS OVARIAN CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to improve ovarian cancer maintenance with fewer dropouts
Disease control Not yet recruitingThis trial tests whether fluzoparib plus bevacizumab works as well as the standard olaparib plus bevacizumab for maintenance therapy in women with HRD-positive advanced ovarian cancer after initial chemotherapy. The study enrolls about 120 participants and tracks how long they st…
Matched conditions: HIGH-GRADE SEROUS OVARIAN CARCINOMA
Phase: PHASE2 • Sponsor: Shandong University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo targets tough ovarian cancers
Disease control Not yet recruitingThis early-stage trial tests two experimental drugs, XmAb541 and XmAb808, in people with advanced ovarian cancer that has come back or spread. The main goal is to see if the combination is safe and find the best dose. About 90 adults with a specific tumor marker (CLDN6) will take…
Matched conditions: HIGH-GRADE SEROUS OVARIAN CARCINOMA
Phase: PHASE1 • Sponsor: Xencor, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC